A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis-Reference-Cited by-同舟云学术

A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis

Published:2018-02-23 Issue:2 Volume:9 Page:673-682
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Gao Yue,Wang Ke,Chen Yun,Shen Li,Hou Jianing,Xuan Jianwei,Liu Bao

Funder

Lilly Suzhou Pharmaceutical Co. Ltd, China

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13300-018-0382-8.pdf

Reference15 articles.

1. International Diabetes Federation. IDF diabetes atlas—7th edition. http://www.idf.org/diabetesatlas . Accessed Aug 2017.

2. Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health. 2005;4:2.

3. Pan C, Yang W, Jia W, et al. Management of Chinese patients with type 2 diabetes, 1998–2006: the Diabcare-China surveys. Curr Med Res Opin. 2009;25:39–45.

4. Yang J, Li J. Premixed or basal insulin: the insulin initiation consideration in Chinese patients with type 2 diabetes mellitus. Chin J Endocrinol Metab. 2013;29:5b-1.

5. Palmer JL, Beaudet A, White J, et al. Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China. Adv Ther. 2010;27:814–27.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Blood Glucose Variability Between Exenatide and Biphasic Insulin Aspart 30 in Chinese Participants with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A Multicenter, Open-Label, Randomized Trial;Diabetes Therapy;2020-08-27

2. Injectable combination therapies for the management of diabetes: an Indian perspective;Expert Opinion on Drug Metabolism & Toxicology;2020-03-02

3. Legitimacy and potential savings in automatic substitution of biological products in Poland, the example of insulin;Acta Poloniae Pharmaceutica - Drug Research;2018-10-31